{"meta":{"query_hash":"2e648224afc0","filters":{"venue":"Surgical Update International Journal of Surgery and Orthopedics"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2e648224afc0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Surgical+Update+International+Journal+of+Surgery+and+Orthopedics"},"results":[{"id":"W3020398921","doi":"10.17511/ijoso.2019.i03.09","title":"A real life experience with novel biosimilar InfimabTM in biologic naive patients with active rheumatoid arthritis","year":2019,"lang":"en","type":"article","venue":"Surgical Update International Journal of Surgery and Orthopedics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Biosimilar; Erythrocyte sedimentation rate; Rheumatoid arthritis; Infliximab; Internal medicine; Adverse effect; Visual analogue scale; Methotrexate; Physical therapy; Disease","score_opus":0.014851527391208853,"score_gpt":0.25739482511318906,"score_spread":0.24254329772198022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020398921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974836,0.0006322476,0.000095658,0.0006789779,0.0006166592,0.00010701215,0.00010320883,0.000009240779,0.00027338247],"genre_scores_gemma":[0.9923973,0.0067093344,0.00032575673,0.000435029,0.000042571126,0.000003087423,0.000041863324,0.000011083419,0.000033993325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984666,0.00015714706,0.000632993,0.00026571288,0.00019708072,0.00028043948],"domain_scores_gemma":[0.998331,0.00058972836,0.00043712292,0.00010282453,0.00044406566,0.000095245334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005325167,0.00020939604,0.00055721146,0.00026149134,0.000046263525,0.00003379479,0.00019446817,0.00021112528,0.00049981783],"category_scores_gemma":[0.00015170353,0.00012541842,0.00010914291,0.00021370602,0.00038337213,0.0003143393,0.00008985325,0.00047917396,0.000008235809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053215194,0.00043418538,0.97671753,0.000006986578,0.0003094603,0.00022164673,0.00014210568,0.00001107859,0.00030649116,0.00045999658,0.000086668166,0.015982345],"study_design_scores_gemma":[0.011718211,0.0012788115,0.91974014,0.00092877593,0.000041873944,0.0013603218,0.000777663,0.000026527034,0.0026272754,0.00010807258,0.060640376,0.00075194734],"about_ca_topic_score_codex":0.000020292844,"about_ca_topic_score_gemma":0.000009773885,"teacher_disagreement_score":0.060553707,"about_ca_system_score_codex":0.000035261586,"about_ca_system_score_gemma":0.00015269262,"threshold_uncertainty_score":0.54726547},"labels":[],"label_agreement":null}]}